These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37469916)

  • 1. Adverse Events among Beneficiaries who Received a Dose of Sputnik V Vaccine at a Tertiary Care Hospital in Coastal Karnataka, India.
    Ameer BR; Akshaya KM; Bhargava M; Jamal J
    Indian J Community Med; 2023; 48(3):418-421. PubMed ID: 37469916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.
    Jose M; Rajmohan P; Thomas J; Krishna S; Antony B; Gopinathan UU; Iyyapan EM; Porinchu RM; Jose P; Raphael L; Kuttichira P
    Curr Drug Saf; 2022; 17(4):327-334. PubMed ID: 35135453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and determinants of adverse events following ChAdOx1 nCoV-19 vaccination (COVISHIELD) - A retrospective cohort study among healthcare workers in central Karnataka, India.
    Davalagi SB; Nayak VP; Ghose A; Marakatti SS; Kasturi ES; Maganahalli AS
    J Family Med Prim Care; 2023 Nov; 12(11):2869-2874. PubMed ID: 38186765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of Sputnik V, Oxford-AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran.
    Oghazian S; Tavanaei Tamanaei T; Haghighi R; Faregh M; Oghazian MB
    Int Immunopharmacol; 2023 Apr; 117():109784. PubMed ID: 36812676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following immunisation with the first dose of sputnik V among Iranian health care providers.
    Jafarzadeh Esfehani R; Zahmatkesh M; Goldozian R; Farkhonde J; Jaripour E; Hatami A; Bidkhori HR; Shamsian SK; Shamsian SA; Mojahedi F
    Clin Exp Vaccine Res; 2023 Jan; 12(1):25-31. PubMed ID: 36844688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects following COVID-19 vaccination in Iran.
    Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M
    BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
    Jarynowski A; Semenov A; Kamiński M; Belik V
    J Med Internet Res; 2021 Nov; 23(11):e30529. PubMed ID: 34662291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-directed Sputnik V (GAM-COVID-VAC) surveillance program: a prospective observational study in Southern India.
    Karattuthodi MS; Chandrasekher D; Panakkal LM; C S; Salman M; Megha ; E MS; Fasil M; A M M; Reji M
    J Basic Clin Physiol Pharmacol; 2023 Jul; 34(4):509-517. PubMed ID: 35172420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study.
    Velhal GD; Kamath YV; Agrawal AS; Vora DS; Dwivedi VR
    Indian J Community Med; 2022; 47(4):613-617. PubMed ID: 36742958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
    Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of Antibody Response to Repeated Vaccination with Sputnik V: A Pilot Study with a Series of Five Cases.
    Boshku AA; Aleksovski V; Tofoski G; Spasova R
    EJIFCC; 2022 Aug; 33(2):175-186. PubMed ID: 36313912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sputnik V vaccine perception and hesitancy in a tertiary health care centre transformed to Covid-19 vaccine centre: A case study.
    Priyadharshini A; Begum J; Ali SI; Pattnaik S; Sharma D; Lalitha DL
    J Educ Health Promot; 2023; 12():366. PubMed ID: 38144010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance.
    Montalti M; Soldà G; Di Valerio Z; Salussolia A; Lenzi J; Forcellini M; Barvas E; Guttmann S; Messina R; Poluzzi E; Raschi E; Riccardi R; Fantini MP; La Fauci G; Gori D;
    EClinicalMedicine; 2021 Aug; 38():101027. PubMed ID: 34505029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
    Jose D; Dhupdale N; Cacodcar JA; Kamat U
    Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India.
    Kaur U; Fatima Z; Maheshwari K; Sahni V; Dehade A; Kl A; Yadav AK; Kansal S; Jaisawal V; Chakrabarti SS
    Drug Saf; 2023 Jun; 46(6):553-563. PubMed ID: 37133805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
    Chakraborty A; Reval N; Kamath L
    Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with development of adverse events after taking COVID-19 vaccine in a tribal state of India: Regression analysis.
    Kujur M; Kiran KA; Nag AR; Soren SK; Kujur A
    J Family Med Prim Care; 2022 Oct; 11(10):6260-6267. PubMed ID: 36618180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.